Efficacy of Bifidobacterium breve CECT7263 for infantile colic treatment: an open-label, parallel, randomised, controlled trial
In: Beneficial MicrobesSearch for other papers by J.A. Maldonado-Lobón in
Current site
Google Scholar
Search for other papers by R. Blanco-Rojo in
Current site
Google Scholar
Pediatric Department, University of Granada, Granada, Spain.
Biosanitary Research Institute (IBS), Granada, Spain.
Maternal and Child Health and Development Network (SAMID), Health Institute Carlos III, Madrid, Spain.
Search for other papers by J. Maldonado in
Current site
Google Scholar
Search for other papers by M.A. Ali in
Current site
Google Scholar
Search for other papers by M.V. Almazán in
Current site
Google Scholar
Search for other papers by A. Suanes-Cabello in
Current site
Google Scholar
Search for other papers by E. Callejón in
Current site
Google Scholar
Search for other papers by R. Jaldo in
Current site
Google Scholar
Search for other papers by M.R. Benavídes in
Current site
Google Scholar
Search for other papers by A.M. Negrillo in
Current site
Google Scholar
Search for other papers by A. Sañudo in
Current site
Google Scholar
Search for other papers by C. Rodríguez in
Current site
Google Scholar
Search for other papers by O. Bañuelos in
Current site
Google Scholar
Faculty of Pharmacy, University of Granada, Campus Universitario de Cartuja, 18071, Granada, Spain.
Search for other papers by J. Fonollá in
Current site
Google Scholar
Search for other papers by M. Olivares in
Current site
Google Scholar
Search for other papers by the PROBI-COLIC group in
Current site
Google Scholar
Infantile colic is a prevalent condition characterised by excessive crying with no effective treatment available. We aimed to evaluate the efficacy of Bifidobacterium breve CECT7263 and a combination of this and Lactobacillus fermentum CECT5716 versus simethicone in reducing the daily time spent crying in colicky infants. A multicentre randomised, open-label, parallel, controlled trial of 28 days was performed in 150 infants who were diagnosed with colic according to the Rome III criteria and who randomly received simethicone (80 mg/day; Simethicone group), B. breve CECT7263 (2×108 cfu/day, Bb group), or a combination of L. fermentum CECT5716 and B. breve CECT7263 (1×108 cfu/day per strain, Bb+Lf group). The main outcomes were minutes of crying per day and the percentage of reduction in daily crying from baseline. Data were analysed per intention to treat. All treatments significantly decreased the daily crying time at the end of the intervention (P-time <0.001). However, the infants in the Bb group had significantly decreased crying time from the first week of the study (P<0.05), whereas the Bb+Lf group and the simethicone group had significantly decreased crying time from the second week (P<0.05). The percentage of reduction in the minutes of crying from baseline in the Bb group was significantly higher than that in the Simethicone group every week of the intervention (-40.3 vs -27.6% at 1-week; -59.2 vs -43.2% at 2-weeks; -64.5 vs -53.5% at 3-week and -68.5 vs -59.5% at 4-weeks, P<0.05). Additionally, in the Bb group, infants had better night sleep, and parents reported a more positive mood at the end of the intervention. All the products used in the study were safe and well tolerated. In conclusion, the breastmilk-isolated probiotic strain B. breve CECT7263 is a safe and effective treatment for infantile colic, presenting an earlier and more robust effect than the reference prescribed drug, simethicone.
-
Algieri, F., Rodriguez-Nogales, A., Garrido-Mesa, N., Zorrilla, P., Rodríguez-Cabezas, M.E., Utrilla, M.P., Olivares, M., Zarzuelo, A. and Gálvez, J., 2013. Intestinal anti-inflammatory effects of Bifidobacterium breve CECT7263 in the TNBS model of rat colitis. Nutricion Hospitalaria 28, Suppl. 1: 28.
'Intestinal anti-inflammatory effects of Bifidobacterium breve CECT7263 in the TNBS model of rat colitis ' () 28 Nutricion Hospitalaria : 28.
-
Ashraf, M.W., Ayaz, S.B., Ashraf, M.N., Matee, S. and Shoaib, M., 2015. Probiotics are effective in alleviating infantile colic; results of a randomized controlled trial held at Benazir Bhutto Hospital, Rawalpindi, Pakistan. Rawal Medical Journal 40: 277-280.
'Probiotics are effective in alleviating infantile colic; results of a randomized controlled trial held at Benazir Bhutto Hospital, Rawalpindi, Pakistan ' () 40 Rawal Medical Journal : 277 -280.
-
Baglatzi, L., Gavrili, S., Stamouli, K., Zachaki, S., Favre, L., Pecquet, S., Benyacoub, J. and Costalos, C., 2016. Effect of infant formula containing a low dose of the probiotic Bifidobacterium lactis CNCM I-3446 on immune and gut functions in C-section delivered babies: a pilot study. Clinical Medicine Insights: Pediatrics 10: 11-19. https://doi.org/10.4137/CMPed.S33096
-
Benninga, M.A., Faure, C., Hyman, P.E., St James-Roberts, I., Schechter, N.L. and Nurko, S., 2016. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology 150: 1443-1455. https://doi.org/10.1053/j.gastro.2016.02.016
-
Chau, K., Lau, E., Greenberg, S., Jacobson, S., Yazdani-Brojeni, P., Verma, N. and Koren, G., 2015. Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. Journal of Pediatrics 166: 74-78. https://doi.org/10.1016/j.jpeds.2014.09.020
-
Daelemans, S., Peeters, L., Hauser, B. and Vandenplas, Y., 2018. Recent advances in understanding and managing infantile colic. F1000 Research 7: 1426. https://doi.org/10.12688/f1000research.14940.1
-
De Weerth, C., Fuentes, S., Puylaert, P. and De Vos, W.M., 2013. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics 131: e550-e558. https://doi.org/10.1542/peds.2012-1449
-
Drug and Therapeutics Bulletin (DTB), 2013. Management of infantile colic. BMJ 347: f4102. https://doi.org/10.1136/bmj.f4102
-
Dubois, N.E. and Gregory, K.E., 2016. Characterizing the intestinal microbiome in infantile colic: findings based on an integrative review of the literature. Biological Research for Nursing 18: 307-315. https://doi.org/10.1177/1099800415620840
-
Fatheree, N.Y., Liu, Y., Taylor, C.M., Hoang, T.K., Cai, C., Rahbar, M.H., Hessabi, M., Ferris, M., McMurtry, V., Wong, C., Vu, T., Dancsak, T., Wang, T., Gleason, W., Bandla, V., Navarro, F., Tran, D.Q. and Rhoads, J.M., 2017. Lactobacillus reuteri for infants with colic: a double-blind, placebo-controlled, randomized clinical trial. Journal of Pediatrics 191: 170-178. https://doi.org/10.1016/j.jpeds.2017.07.036
-
Gil-Campos, M., López, M.Á., Rodriguez-Benítez, M.V., Romero, J., Roncero, I., Linares, M.D., Maldonado, J., López-Huertas, E., Berwind, R., Ritzenthaler, K.L., Navas, V., Sierra, C., Sempere, L., Geerlings, A., Maldonado-Lobón, J.A., Valero, A.D., Lara-Villoslada, F. and Olivares, M., 2012. Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial. Pharmacological Research 65: 231-238. https://doi.org/10.1016/j.phrs.2011.11.016
-
Gupta, S.K., 2002. Is colic a gastrointestinal disorder? Current Opinion in Pediatrics 14: 588-592.
'Is colic a gastrointestinal disorder? ' () 14 Current Opinion in Pediatrics : 588 -592.
-
Hyman, P.E., Milla, P.J., Benninga, M.A., Davidson, G.P., Fleisher, D.F. and Taminiau, J., 2006. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology 130: 1519-1526. https://doi.org/10.1053/j.gastro.2005.11.065
-
Kianifar, H., Ahanchian, H., Grover, Z., Jafari, S., Noorbakhsh, Z., Khakshour, A., Sedaghat, M. and Kiani, M., 2014. Synbiotic in the management of infantile colic: a randomised controlled trial. Journal of Paediatrics and Child Health 50: 801-805. https://doi.org/10.1111/jpc.12640
-
Korpela, K., Renko, M., Paalanne, N., Vänni, P., Salo, J., Tejesvi, M., Koivusaari, P., Pokka, T., Kaukola, T., Pirttilä, A.M. and Tapiainen, T., 2020. Microbiome of the first stool after birth and infantile colic. Pediatric Research 88: 776-783. https://doi.org/10.1038/s41390-020-0804-y
-
Kukkonen, K., Savilahti, E., Haahtela, T., Juntunen-Backman, K., Korpela, R., Poussa, T., Tuure, T. and Kuitunen, M., 2008. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 122: 8-12. https://doi.org/10.1542/peds.2007-1192
-
Lee, S.H., Cho, D.Y., Lee, S.H., Han, K.S., Yang, S.W., Kim, J.H., Lee, S.H., Kim, S.M. and Kim K.N., 2019. A randomized clinical trial of synbiotics in irritable bowel syndrome: dose-dependent effects on gastrointestinal symptoms and fatigue. Korean Journal of Family Medicine 40: 2-8. https://doi.org/10.4082/kjfm.17.0064
-
Lucassen, P.L., Assendelft, W.J., Van Eijk, J., Gubbels, J.W., Douwes, A.C. and Van Geldrop, W.J., 2001 Systematic review of the ocurrence of infantile colic in the community. Archives of Disease in Childhood 84: 398-403. https://doi.org/10.1136/adc.84.5.398
-
Maldonado, J., Cañabate, F., Sempere, L., Vela, F., Sánchez, A.R., Narbona, E., López-Huertas, E., Geerlings, A., Valero, A.D., Olivares, M. and Lara-Villoslada, F., 2012. Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants. Journal of Pediatric Gastroenterology and Nutrition 54: 55-61. https://doi.org/10.1097/MPG.0b013e3182333f18
-
Maldonado, J., Gil-Campos, M., Maldonado-Lobón, J.A., Benavides, M.R., Flores-Rojas, K., Jaldo, R., Jiménez Del Barco, I., Bolívar, V., Valero, A.D., Prados, E., Peñalver, I. and Olivares, M., 2019. Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial. BMC Pediatrics 19: 361. https://doi.org/10.1186/s12887-019-1753-7
-
Maldonado-Lobón, J.A., 2015. The Human Milk Strain Bifidobacterium breve CECT7263 is safe in infants from 1 to 12 months and might improve symptoms of infant colic. Nutricion Hospitalaria 31, Suppl. 1: 144. https://doi.org/10.3305/nh.2015.31.sup1.8717
-
Maldonado-Lobón, J.A., Gil-Campos, M., Maldonado, J., López-Huertas, E., Flores-Rojas, K., Valero, A.D., Rodríguez-Benítez, M.V., Bañuelos, O., Lara-Villoslada, F., Fonollá, J. and Olivares, M., 2015. Long-term safety of early consumption of Lactobacillus fermentum CECT5716: a 3-year follow-up of a randomized controlled trial. Pharmacological Research 95-96: 12-19. https://doi.org/10.1016/j.phrs.2015.01.006
-
Mi, G.-L., Zhao, L., Qiao, D.-D., Kang, W.-Q., Tang, M.-Q. and Xu, J.-K., 2015. Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial. Antonie van Leeuwenhoek 107: 1547-1553. https://doi.org/10.1007/s10482-015-0448-9
-
Nagpal, R., Kurakawa, T., Tsuji, H., Takahashi, T., Kawashima, K., Nagata, S., Nomoto, K. and Yamashiro, Y., 2017. Evolution of gut Bifidobacterium population in healthy Japanese infants over the first three years of life: a quantitative assessment. Scientific Reports 7: 10097. https://doi.org/10.1038/s41598-017-10711-5
-
Nocerino, R., De Filippis, F., Cecere, G., Marino, A., Micillo, M., Di Scala, C., De Caro, C., Calignano, A., Bruno, C., Paparo, L., Iannicelli, A.M., Cosenza, L., Maddalena, Y., Della Gatta, G., Coppola, S., Carucci, L., Ercolini, D. and Berni Canani, R., 2020. The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12® in infant colic: a randomised, double blind, placebo-controlled trial. Alimentary Pharmacology and Therapeutics 51: 110-120. https://doi.org/10.1111/apt.15561
-
Ong, T.G., Gordon, M., Banks, S.S., Thomas, M.R. and Akobeng, A.K., 2019. Probiotics to prevent infantile colic. Cochrane Database of Systematic Reviews 3. https://doi.org/10.1002/14651858.CD012473.pub2
-
Pärtty, A., Kalliomäki, M., Endo, A., Salminen, S. and Isolauri, E., 2012. Compositional development of Bifidobacterium and Lactobacillus microbiota is linked with crying and fussing in early infancy. PLoS ONE 7: e32495. https://doi.org/10.1371/journal.pone.0032495
-
Pärtty, A., Kalliomäki, M., Salminen, S. and Isolauri, E., 2017. Infantile colic is associated with low-grade systemic inflammation. Journal of Pediatric Gastroenterology and Nutrition 64: 691-695. https://doi.org/10.1097/mpg.0000000000001340
-
Pärtty, A., Lehtonen, L., Kalliomäki, M., Salminen, S. and Isolauri, E., 2015. Probiotic Lactobacillus rhamnosus GG therapy and microbiological programming in infantile colic: a randomized, controlled trial. Pediatric Research 78: 470-475. https://doi.org/10.1038/pr.2015.127
-
Quigley, E.M.M., 2017. Bifidobacterium breve. In: Floch, M.H., Ringel, Y. and Allan Walker, W. (eds.) The microbiota in gastrointestinal pathophysiology. Academic Press, Boston, MA, USA, pp. 135-137. https://doi.org/10.1016/B978-0-12-804024-9.00015-X
-
Radesky, J.S., Zuckerman, B., Silverstein, M., Rivara, F.P., Barr, M., Taylor, J.A., Lengua, L.J. and Barr, R.G., 2013. Inconsolable infant crying and maternal postpartum depressive symptoms. Pediatrics 131: e1857-e1864. https://doi.org/10.1542/peds.2012-3316
-
Rhoads, J.M., Collins, J., Fatheree, N.Y., Hashmi, S.S., Taylor, C.M., Luo, M., Hoang, T.K., Gleason, W.A., Van Arsdall, M.R., Navarro, F. and Liu, Y., 2018. Infant colic represents gut inflammation and dysbiosis. Journal of Pediatrics 203: 55-61. https://doi.org/10.1016/j.jpeds.2018.07.042
-
Rhoads, J.M., Fatheree, N.Y., Norori, J., Liu, Y., Lucke, J.F., Tyson, J.E. and Ferris, M.J., 2009. Altered fecal microflora and increased fecal calprotectin in infants with colic. Journal of Pediatrics 155: 823-828. https://doi.org/10.1016/j.jpeds.2009.05.012
-
Robles-Vera, I., Toral, M., De la Visitación, N., Sánchez, M., Gómez-Guzmán, M., Romero, M., Yang, T., Izquierdo-Garcia, J.L., Jiménez, R., Ruiz-Cabello, J., Guerra-Hernández, E., Raizada, M.K., Pérez-Vizcaíno, F. and Duarte, J., 2020. Probiotics prevent dysbiosis and the rise in blood pressure in genetic hypertension: role of short-chain fatty acids. Molecular Nutrition and Food Research 64: e1900616. https://doi.org/10.1002/mnfr.201900616
-
Rodríguez, J.M., Murphy, K., Stanton, C., Ross, R.P., Kober, O.I., Juge, N., Avershina, E., Rudi, K., Narbad, A., Jenmalm, M.C., Marchesi, J.R. and Collado, M.C., 2015. The composition of the gut microbiota throughout life, with an emphasis on early life. Microbial Ecology in Health and Disease 26: 26050. https://doi.org/10.3402/mehd.v26.26050
-
Sadeh, A., Sivan, Y., 2009. Clinical practice: sleep problems during infancy. European Journal of Pediatrics 168: 1159-1164. https://doi.org/10.1007/s00431-009-0982-4
-
Savino, F., Cordisco, L., Tarasco, V., Calabrese, R., Palumeri, E. and Matteuzzi, D., 2009. Molecular identification of coliform bacteria from colicky breastfed infants. Acta Paediatrica 98: 1582-1588. https://doi.org/10.1111/j.1651-2227.2009.01419.x
-
Savino, F., Garro, M., Montanari, P., Galliano, I. and Bergallo, M., 2018. Crying time and RORγ/FOXP3 expression in Lactobacillus reuteri DSM17938-treated infants with colic: a randomized trial. Journal of Pediatrics 192: 171-177. https://doi.org/10.1016/j.jpeds.2017.08.062.
-
Schreck Bird, A., Gregory, P.J., Jalloh, M.A., Risoldi Cochrane, Z. and Hein, D.J., 2017. Probiotics for the treatment of infantile colic: a systematic review. Journal of Pharmacy Practice 30: 366-374. https://doi.org/10.1177/0897190016634516
-
Sung, V., 2018. Infantile colic. Australian Prescriber 41: 105-110. https://doi.org/10.18773/austprescr.2018.033
-
Sung, V., D’Amico, F., Cabana, M.D., Chau, K., Koren, G., Savino, F., Szajewska, H., Deshpande, G., Dupont, C., Indrio, F., Mentula, S., Partty, A. and Tancredi, D., 2018. Lactobacillus reuteri to treat infant colic: a meta-analysis. Pediatrics 141: e20171811. https://doi.org/10.1542/peds.2017-1811
-
Sung, V., Hiscock, H., Tang, M.L.K., Mensah, F.K., Nation, M.L., Satzke, C., Heine, R.G., Stock, A., Barr, R.G. and Wake, M., 2014. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ 348: g2107. https://doi.org/10.1136/bmj.g2107
-
Szajewska, H., Gyrczuk, E. and Horvath, A., 2013. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. Journal of Pediatrics 162: 257-262. https://doi.org/10.1016/j.jpeds.2012.08.004
-
Turroni, F., Milani, C., Duranti, S., Ferrario, C., Lugli, G.A., Mancabelli, L., Van Sinderen, D. and Ventura, M., 2018. Bifidobacteria and the infant gut: an example of co-evolution and natural selection. Cellular and Molecular Life Sciences 75: 103-118. https://doi.org/10.1007/s00018-017-2672-0
-
Vandenplas, Y., Abkari, A., Bellaiche, M., Benninga, M., Chouraqui, J., Çokura, F., Harb, T., Hegar, B., Lifschitz, C., Ludwig, T., Miqdady, M., Morais, M. de, Osatakul, S., Salvatore, S., Shamir, R., Staiano, A., Szajewska, H. and Thapar, N., 2015. Prevalence and health outcomes of functional gastrointestinal symptoms in infants from birth to 12 months of age. Journal of Pediatric Gastroenterology and Nutrition 61: 531-537. https://doi.org/10.1097/MPG.0000000000000949
-
Vik, T., Grote, V., Escribano, J., Socha, J., Verduci, E., Fritsch, M., Carlier, C., Von Kries, R., Koletzko, B., European Childhood Obesity Trial Study Group, 2009. Infantile colic, prolonged crying and maternal postnatal depression. Acta Paediatrica 98: 1344-1348. https://doi.org/10.1111/j.1651-2227.2009.01317.x
-
Vlieger, A.M., Robroch, A., Van Buuren, S., Kiers, J., Rijkers, G., Benninga, M.A. and Biesebeke, R., 2009. Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial. British Journal of Nutrition 102: 869-875. https://doi.org/10.1017/S0007114509289069
-
Xinias, I., Analitis, A., Mavroudi, A., Roilides, I., Lykogeorgou, M., Delivoria, V., Milingos, V., Mylonopoulou, M. and Vandenplas, Y., 2017. Innovative dietary intervention answers to baby colic. Pediatric Gastroenterology, Hepatology and Nutrition 20: 100-106. https://doi.org/10.5223/pghn.2017.20.2.100
-
Zeevenhooven, J., Browne, P.D., L’Hoir, M.P., De Weerth, C. and Benninga, M.A., 2018. Infant colic: mechanisms and management. Nature Reviews Gastroenterology and Hepatology 15: 479-496. https://doi.org/10.1038/s41575-018-0008-7
-
Zhang, Y., Li, L., Guo, C., Mu, D., Feng, B., Zuo, X. and Li, Y., 2016. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterology 16: 62. https://doi.org/10.1186/s12876-016-0470-z
Supplementary Materials
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 1343 | 430 | 43 |
| PDF Views & Downloads | 1585 | 503 | 72 |
Efficacy of Bifidobacterium breve CECT7263 for infantile colic treatment: an open-label, parallel, randomised, controlled trial
In: Beneficial MicrobesSearch for other papers by J.A. Maldonado-Lobón in
Current site
Google Scholar
PubMed
Search for other papers by R. Blanco-Rojo in
Current site
Google Scholar
PubMed
Pediatric Department, University of Granada, Granada, Spain.
Biosanitary Research Institute (IBS), Granada, Spain.
Maternal and Child Health and Development Network (SAMID), Health Institute Carlos III, Madrid, Spain.
Search for other papers by J. Maldonado in
Current site
Google Scholar
PubMed
Search for other papers by M.A. Ali in
Current site
Google Scholar
PubMed
Search for other papers by M.V. Almazán in
Current site
Google Scholar
PubMed
Search for other papers by A. Suanes-Cabello in
Current site
Google Scholar
PubMed
Search for other papers by E. Callejón in
Current site
Google Scholar
PubMed
Search for other papers by R. Jaldo in
Current site
Google Scholar
PubMed
Search for other papers by M.R. Benavídes in
Current site
Google Scholar
PubMed
Search for other papers by A.M. Negrillo in
Current site
Google Scholar
PubMed
Search for other papers by A. Sañudo in
Current site
Google Scholar
PubMed
Search for other papers by C. Rodríguez in
Current site
Google Scholar
PubMed
Search for other papers by O. Bañuelos in
Current site
Google Scholar
PubMed
Faculty of Pharmacy, University of Granada, Campus Universitario de Cartuja, 18071, Granada, Spain.
Search for other papers by J. Fonollá in
Current site
Google Scholar
PubMed
Search for other papers by M. Olivares in
Current site
Google Scholar
PubMed
Search for other papers by the PROBI-COLIC group in
Current site
Google Scholar
PubMed
Infantile colic is a prevalent condition characterised by excessive crying with no effective treatment available. We aimed to evaluate the efficacy of Bifidobacterium breve CECT7263 and a combination of this and Lactobacillus fermentum CECT5716 versus simethicone in reducing the daily time spent crying in colicky infants. A multicentre randomised, open-label, parallel, controlled trial of 28 days was performed in 150 infants who were diagnosed with colic according to the Rome III criteria and who randomly received simethicone (80 mg/day; Simethicone group), B. breve CECT7263 (2×108 cfu/day, Bb group), or a combination of L. fermentum CECT5716 and B. breve CECT7263 (1×108 cfu/day per strain, Bb+Lf group). The main outcomes were minutes of crying per day and the percentage of reduction in daily crying from baseline. Data were analysed per intention to treat. All treatments significantly decreased the daily crying time at the end of the intervention (P-time <0.001). However, the infants in the Bb group had significantly decreased crying time from the first week of the study (P<0.05), whereas the Bb+Lf group and the simethicone group had significantly decreased crying time from the second week (P<0.05). The percentage of reduction in the minutes of crying from baseline in the Bb group was significantly higher than that in the Simethicone group every week of the intervention (-40.3 vs -27.6% at 1-week; -59.2 vs -43.2% at 2-weeks; -64.5 vs -53.5% at 3-week and -68.5 vs -59.5% at 4-weeks, P<0.05). Additionally, in the Bb group, infants had better night sleep, and parents reported a more positive mood at the end of the intervention. All the products used in the study were safe and well tolerated. In conclusion, the breastmilk-isolated probiotic strain B. breve CECT7263 is a safe and effective treatment for infantile colic, presenting an earlier and more robust effect than the reference prescribed drug, simethicone.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 1343 | 430 | 43 |
| PDF Views & Downloads | 1585 | 503 | 72 |
